These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17379480)

  • 41. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts.
    Chen W; Saxena A; Li N; Sun J; Gupta A; Lee DW; Tian Q; Dobaczewski M; Frangogiannis NG
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2598-608. PubMed ID: 22995519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells.
    Talreja J; Talwar H; Ahmad N; Rastogi R; Samavati L
    J Immunol; 2016 Aug; 197(4):1368-78. PubMed ID: 27402699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IRAK-M has effects in regulation of lung epithelial inflammation.
    Li J; Zheng Z; Liu Y; Zhang H; Zhang Y; Gao J
    Respir Res; 2023 Apr; 24(1):103. PubMed ID: 37029363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active ERK contributes to protein translation by preventing JNK-dependent inhibition of protein phosphatase 1.
    Monick MM; Powers LS; Gross TJ; Flaherty DM; Barrett CW; Hunninghake GW
    J Immunol; 2006 Aug; 177(3):1636-45. PubMed ID: 16849472
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Feng J; Meng W; Chen L; Zhang X; Markazi A; Yuan W; Huang Y; Gao SJ
    mBio; 2023 Feb; 14(1):e0334922. PubMed ID: 36625590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo interstitial migration of primitive macrophages mediated by JNK-matrix metalloproteinase 13 signaling in response to acute injury.
    Zhang Y; Bai XT; Zhu KY; Jin Y; Deng M; Le HY; Fu YF; Chen Y; Zhu J; Look AT; Kanki J; Chen Z; Chen SJ; Liu TX
    J Immunol; 2008 Aug; 181(3):2155-64. PubMed ID: 18641354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists.
    Vollmer S; Strickson S; Zhang T; Gray N; Lee KL; Rao VR; Cohen P
    Biochem J; 2017 Jun; 474(12):2027-2038. PubMed ID: 28512203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-1 Receptor-Associated Kinase-1 (IRAK-1) functionally associates with PKCepsilon and VASP in the regulation of macrophage migration.
    Gan L; Li L
    Mol Immunol; 2010 Mar; 47(6):1278-82. PubMed ID: 20044140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation.
    Ringwood L; Li L
    Cytokine; 2008 Apr; 42(1):1-7. PubMed ID: 18249132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of IL-1 receptor-associated kinase-4 gene silencing on human osteoblast-like cells.
    Yang Z; Huang B; Zhang Z; Kang Y; Fu M; Liao W
    Connect Tissue Res; 2012; 53(6):498-507. PubMed ID: 22606974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase.
    Scarneo SA; Hughes PF; Yang KW; Carlson DA; Gurbani D; Westover KD; Haystead TAJ
    J Biol Chem; 2020 Feb; 295(6):1565-1574. PubMed ID: 31914413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases.
    Kim YI; Park JE; Martinez-Hernandez A; Yi AK
    J Biol Chem; 2008 May; 283(22):15258-70. PubMed ID: 18378686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling.
    Moynagh PN
    Trends Immunol; 2009 Jan; 30(1):33-42. PubMed ID: 19022706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy.
    Singer JW; Fleischman A; Al-Fayoumi S; Mascarenhas JO; Yu Q; Agarwal A
    Oncotarget; 2018 Sep; 9(70):33416-33439. PubMed ID: 30279971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses.
    Zhang Y; Diao N; Lee CK; Chu HW; Bai L; Li L
    Mol Ther; 2020 Jan; 28(1):89-99. PubMed ID: 31607540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of IRAK-M in alcohol induced liver injury.
    Wang Y; Hu Y; Chao C; Yuksel M; Colle I; Flavell RA; Ma Y; Yan H; Wen L
    PLoS One; 2013; 8(2):e57085. PubMed ID: 23437317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of innate immune signaling by IRAK proteins.
    Pereira M; Gazzinelli RT
    Front Immunol; 2023; 14():1133354. PubMed ID: 36865541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients.
    Escoll P; del Fresno C; García L; Vallés G; Lendínez MJ; Arnalich F; López-Collazo E
    Biochem Biophys Res Commun; 2003 Nov; 311(2):465-72. PubMed ID: 14592437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IRAK family in inflammatory autoimmune diseases.
    Su LC; Xu WD; Huang AF
    Autoimmun Rev; 2020 Mar; 19(3):102461. PubMed ID: 31917263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of Inflammation by IRAK-M Pathway Can Be Associated with nAchRalpha7 Activation and COVID-19.
    Rieder AS; Wyse ATS
    Mol Neurobiol; 2024 Feb; 61(2):581-592. PubMed ID: 37640915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.